About the Biosimilars Council
The GPhA Biosimilars Council works to ensure a positive regulatory, reimbursement, political and policy environment for biosimilar products, and will educate the public and patients about the safety and effectiveness of biosimilars. Areas of focus will include education, access, the nascent regulatory environment, reimbursement and legal affairs. Member organizations include any company or stakeholder organization working to develop biosimilar products with the intent to compete in the U.S. market.
Please email firstname.lastname@example.org for more information.
2015 Biosimilars Council members:
• Accord Healthcare
• Amneal BioSciences, LLC
• Dr. Reddy’s
• Momenta Pharmaceuticals, Inc.
• Mylan Inc.
• Pfenex Inc.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceuticals USA
• Zydus Pharmaceuticals